… We focused on the comparison of moxifloxacin monotherapy to ß-lactam monotherapy and
to ß-lactam … We tested moxifloxacin monotherapy versus ß-lactam monotherapy, as well as …

… of moxifloxacin monotherapy with that of β-lactam-based standard therapy for CAP
patients. This meta-analysis indicates that moxifloxacin monotherapy … compared with β-lactam-based …

… We tested the hypothesis that moxifloxacin monotherapy is equally effective and safe as
a betalactam antibiotic based combination therapy in patients with acute respiratory distress …

… as follows: ((pneumonia OR lower respiratory tract infection OR chest infection) AND (fluoroquinolone
OR levofloxacin OR moxifloxacin OR gemifloxacin) AND (β-lactam OR beta-…

… respiratory fluoroquinolone monotherapy and β-lactam with … respiratory fluoroquinolone
monotherapy and β-lactam with or … fluoroquinolone monotherapy (levofloxacin or moxifloxacin), …

… To investigate whether moxifloxacin monotherapy is associated with better clinical outcomes
than other antibiotics recommended for CAP among adults with mild-to-moderate or severe …

… Moxifloxacin monotherapy is recommended by the current … rates of extended-spectrum
β-lactamase (ESBL)-producing … IAIs in Asia, any fluoroquinolones (including moxifloxacin) are not …

… new quinolones in monotherapy are at the same level of efficacy as β‐lactams alone or in
… the free choice by clinician between two monotherapy and one combination therapy options…

… moxifloxacin) with narrow-spectrum antibiotics (amoxicillin, clarithromycin, or cefuroxime-axetil)
and found that moxifloxacin … cure); however, moxifloxacin was associated with a higher …

… In the present study, although both ampicillin-sulbactam and moxifloxacin appeared equivalent
in terms of the clinical response of cIAIs generally, moxifloxacin was more efficacious for …